Selected article for: "corona virus and report case"

Author: Al-Sadawi, Mohammed; Mohiuddin, Amena; Hossain, Naseem; Shaikh, Shakil; Feit, Alan; Ramalanjaona, Benjamin; Salifu, Moro O.; McFarlane, Samy I.
Title: Management of ST-Elevation Myocardial Infarction in the COVID-19 Era: The Role of Thrombosis and Anticoagulation Strategy
  • Cord-id: 14isctdl
  • Document date: 2020_5_22
  • ID: 14isctdl
    Snippet: Cardiac manifestations of COVID-19 include myocarditis, demand ischemia, myocardial infarction and arrhythmias with prothrombotic state being a major underlying pathogenetic mechanism. In this report we present a case of a 57-year-old, otherwise healthy, woman who presented with chest pain and nausea and was found to have an inferior wall ST-elevation myocardial infarction (STEMI) in the setting of an active COVID-19 infection. Angiography revealed tortuous coronary arteries with a 100% right co
    Document: Cardiac manifestations of COVID-19 include myocarditis, demand ischemia, myocardial infarction and arrhythmias with prothrombotic state being a major underlying pathogenetic mechanism. In this report we present a case of a 57-year-old, otherwise healthy, woman who presented with chest pain and nausea and was found to have an inferior wall ST-elevation myocardial infarction (STEMI) in the setting of an active COVID-19 infection. Angiography revealed tortuous coronary arteries with a 100% right coronary artery occlusion with high thrombus burden and normal left coronary system. In light of the available literature regarding the pro-thrombotic effects of this novel corona virus, we continued full dose anticoagulation with Enoxaparin after the cardiac catheterization and transitioned to rivaroxaban and we also continued the patient on dual antiplatelet therapy prior to discharge.

    Search related documents:
    Co phrase search for related documents
    • acs management and acute coronary syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • acs management and acute patient: 1
    • acs management and address need: 1, 2
    • acute coronary syndrome and address need: 1, 2
    • acute coronary syndrome and loading dose: 1, 2
    • acute patient and loading dose: 1
    • acute patient and long term management: 1, 2
    • acute respiratory failure and loading dose: 1
    • acute respiratory failure and long term management: 1, 2, 3
    • address need and long term management: 1
    • long term management and low dose rivaroxaban: 1